Does MARALIXIBAT Cause Product dose omission issue? 25 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 25 reports of Product dose omission issue have been filed in association with MARALIXIBAT (Livmarli). This represents 3.1% of all adverse event reports for MARALIXIBAT.
25
Reports of Product dose omission issue with MARALIXIBAT
3.1%
of all MARALIXIBAT reports
0
Deaths
1
Hospitalizations
How Dangerous Is Product dose omission issue From MARALIXIBAT?
Of the 25 reports, 1 (4.0%) required hospitalization, and 1 (4.0%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MARALIXIBAT. However, 25 reports have been filed with the FAERS database.
What Other Side Effects Does MARALIXIBAT Cause?
Pruritus (221)
Off label use (110)
Drug ineffective (72)
Diarrhoea (71)
Liver transplant (58)
Hepatic enzyme increased (56)
Blood bilirubin increased (36)
Vomiting (35)
Jaundice (33)
Alanine aminotransferase increased (30)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which MARALIXIBAT Alternatives Have Lower Product dose omission issue Risk?
MARALIXIBAT vs MARAVIROC
MARALIXIBAT vs MARIBAVIR
MARALIXIBAT vs MAVACAMTEN
MARALIXIBAT vs MEASLES-MUMPS-RUBELLA VIRUS VACCINE
MARALIXIBAT vs MEASLES VIRUS STRAIN ENDERS' ATTENUATED EDMONSTON LIVE ANTIGEN\MUMPS VIRUS STRAIN B LEVEL JERYL LYNN LIVE ANTIGEN\RUBELLA VIRUS STRAIN WISTAR RA 27/3 LIVE ANTIGEN